Merck & Co., Inc. Accounts Receivable 2008-2026 | MRK
Beta
What is accounts receivable?
Accounts receivable represents money owed to the company by customers for goods or services already delivered but not yet paid for.
What is Merck & Co., Inc.'s current accounts receivable?
Merck & Co., Inc. (MRK) annual accounts receivable for 2025 was $11.78B, a 14.57% increase from 2024. Merck & Co., Inc. accounts receivable for the quarter ending March 31, 2026 was $12.21B.
What was Merck & Co., Inc.'s accounts receivable in 2024?
Merck & Co., Inc. annual accounts receivable for 2024 was $10.28B, a 0.69% decline from 2023.
What was Merck & Co., Inc.'s accounts receivable in 2023?
Merck & Co., Inc. annual accounts receivable for 2023 was $10.35B, a 9.51% increase from 2022.
What is Merck & Co., Inc.'s 5-year accounts receivable CAGR?
Merck & Co., Inc. accounts receivable grew at a compound annual growth rate (CAGR) of 11.60% from FY2020 to FY2025, going from $6.80B to $11.78B over 5 years.
Accounts Receivable History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+11.6%
FY2020
$6.80B
→
FY2025
$11.78B
0810111213141516171819202122232425
5 years selected
Accounts Receivable History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $11.78B | +14.6% | 10-K |
| FY2024 | $10.28B | -0.7% | 10-K |
| FY2023 | $10.35B | +9.5% | 10-K |
| FY2022 | $9.45B | +2.4% | 10-K |
| FY2021 | $9.23B | +35.7% | 10-K |
| FY2020 | $6.80B | +0.4% | 10-K |
| FY2019 | $6.78B | -4.1% | 10-K |
| FY2018 | $7.07B | +2.9% | 10-K |
| FY2017 | $6.87B | -2.1% | 10-K |
| FY2016 | $7.02B | +8.2% | 10-K |
| FY2015 | $6.48B | -2.1% | 10-K |
| FY2014 | $6.63B | -7.8% | 10-K |
| FY2013 | $7.18B | -6.4% | 10-K |
| FY2012 | $7.67B | -7.1% | 10-K |
| FY2011 | $8.26B | +12.5% | 10-K |
| FY2010 | $7.34B | +160.8% | 10-K |
| FY2008 | $2.82B | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →